Yes, all suspected adverse reactions to Mounjaro should be reported via the Yellow Card Scheme, particularly serious reactions, those causing hospitalisation, or any reactions not documented in the Summary of Product Characteristics
Especially online therapy with better help
F)Dispropertionation reaction (scission process) of polymer alkoxy radicals with the formation of aldehyde end groups and end polymer alkyl radicals
Acute and chronic pancreatitis can lead to exocrine pancreatic insufficiency (EPI)
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial
Yes, interactions are possible